Profile data is unavailable for this security.
About the company
Shedir Pharma Srl is an Italy-based pharmaceutical company specialized in nutraceuticals, cosmetics and medical devices. The Company markets its products in different forms and under the brand lines Shedir Farmaceutici, Deimos Farmaceutici, Phobos Farmaceutici, Menkar Farmaceutici and Greenplanet Divisione Farmaceutica. Its products cover a wide range of therapeutics areas, such as cardiovascular, dermatology, neurology, urology, gynecology and dental health, among others.
- Revenue in EUR (TTM)58.42m
- Net income in EUR6.12m
- Incorporated--
- Employees74.00
- LocationShedir Pharma Srl UnipersonaleVia San Felice, 41,43MERCATO SAN SEVERINO 84085ItalyITA
- Websitehttps://www.shedirpharma.com/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Lifecare AS | 1.10m | -2.97m | 36.75m | 32.00 | -- | 6.56 | -- | 33.29 | -0.2903 | -0.2903 | 0.1088 | 0.4924 | 0.1621 | -- | 4.90 | 408,943.10 | -43.60 | -40.00 | -49.97 | -45.26 | -- | -- | -269.03 | -175.53 | -- | -- | 0.1812 | -- | -40.88 | 30.29 | -101.74 | -- | -- | -- |
| Mendus AB (publ) | 0.00 | -8.64m | 38.42m | 30.00 | -- | 0.5493 | -- | -- | -0.2554 | -0.2554 | 0.00 | 0.8165 | 0.00 | -- | -- | 0.00 | -14.77 | -18.84 | -15.78 | -20.21 | -- | -- | -- | -28,474.53 | -- | -- | 0.0325 | -- | -100.00 | -- | 26.78 | -- | -- | -- |
| genOway SA | 18.63m | 1.59m | 38.49m | 124.00 | 22.88 | 2.26 | 9.59 | 2.07 | 0.1814 | 0.1814 | 2.12 | 1.84 | 0.5813 | 0.3881 | 2.50 | 142,180.80 | 4.98 | -0.5615 | 6.72 | -0.8058 | 97.61 | 93.72 | 8.56 | -1.12 | 2.10 | 17.42 | 0.3344 | -- | 21.64 | 11.57 | 341.09 | -16.63 | -18.02 | -- |
| Initiator Pharma A/S | 0.00 | -3.06m | 40.29m | 3.00 | -- | 26.72 | -- | -- | -0.6631 | -0.6631 | 0.00 | 0.3352 | 0.00 | -- | -- | 0.00 | -58.55 | -65.10 | -62.50 | -70.59 | -- | -- | -- | -- | -- | -- | 0.5804 | -- | -- | -- | 40.52 | -- | -- | -- |
| MediGene AG | -100.00bn | -100.00bn | 40.68m | 86.00 | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -22.31 | -- | -25.28 | -- | 90.15 | -- | -123.17 | -- | -- | -- | -- | -80.69 | -4.89 | -94.20 | -- | -8.12 | -- |
| Sequana Medical NV | 712.17k | -32.56m | 42.95m | 62.00 | -- | -- | -- | 60.30 | -1.22 | -1.22 | 0.0266 | -0.6905 | 0.0394 | 1.99 | 9.08 | 11,486.61 | -180.28 | -170.42 | -4,305.25 | -660.97 | -586.32 | -255.63 | -4,572.45 | -3,072.27 | 0.2055 | -8.92 | -- | -- | -22.82 | -7.10 | -5.85 | -- | 79.05 | -- |
| Promimic AB | 3.15m | -784.26k | 43.16m | 17.00 | -- | 6.61 | -- | 13.69 | -0.5295 | -0.5295 | 2.08 | 4.11 | 0.3994 | -5.63 | 3.00 | 2,180,588.00 | -9.93 | -24.88 | -11.67 | -29.25 | 103.90 | 101.23 | -24.87 | -89.46 | 3.98 | -- | -- | -- | 128.63 | -- | 41.95 | -- | -- | -- |
| Biosynex SA | 93.05m | -13.79m | 43.18m | 560.00 | -- | -- | -- | 0.4641 | -1.94 | -1.94 | -- | -- | -- | -- | -- | 248,141.30 | -- | 25.60 | -- | 33.90 | 25.22 | 51.82 | -13.15 | 20.26 | -- | -4.45 | -- | 14.72 | -48.61 | 45.12 | -84.99 | 118.26 | -- | -- |
| Shedir Pharma Srl Unipersonale | 58.42m | 6.12m | 43.21m | 74.00 | 7.05 | 1.36 | 4.48 | 0.7395 | 0.5364 | 0.5364 | 5.13 | 2.78 | 1.10 | 1.99 | 6.74 | 800,315.10 | 11.59 | 8.72 | 16.73 | 12.74 | 57.93 | 60.19 | 10.51 | 9.76 | 1.52 | 61.03 | 0.2256 | -- | 19.53 | 6.07 | 50.96 | 11.27 | -- | -- |
| GeNeuro SA | 0.00 | -13.39m | 43.45m | 20.00 | -- | -- | -- | -- | -0.5385 | -0.5385 | 0.00 | -0.2223 | 0.00 | -- | -- | 0.00 | -94.37 | -67.88 | -133.47 | -129.86 | -- | -- | -- | -613.26 | -- | -- | 5.56 | -- | -- | -- | -78.94 | -- | -4.72 | -- |
| Enzymatica AB (publ) | 4.02m | -4.56m | 44.68m | 18.00 | -- | 6.26 | -- | 11.11 | -0.3247 | -0.3247 | 0.2866 | 0.4841 | 0.3269 | 1.38 | 6.48 | -- | -37.11 | -27.36 | -39.16 | -33.98 | 64.25 | 65.08 | -113.50 | -66.12 | -- | -23.26 | 0.2502 | -- | 4.00 | -0.6382 | 27.57 | -- | 7.02 | -- |
| Bergenbio ASA | 29.86k | -16.06m | 47.81m | 18.00 | -- | 3.06 | -- | 1,601.03 | -0.2647 | -0.2647 | 0.0002 | 0.0474 | 0.0021 | -- | -- | -- | -111.66 | -66.15 | -176.09 | -78.74 | -- | -- | -53,785.59 | -11,419.44 | -- | -- | 0.00 | -- | -9.00 | -31.43 | 36.98 | -- | -- | -- |
| Arecor Therapeutics PLC | 3.96m | -11.03m | 48.96m | 51.00 | -- | 3.16 | -- | 12.37 | -0.3108 | -0.3108 | 0.1114 | 0.4314 | 0.1805 | -- | 0.7516 | 66,254.90 | -50.32 | -- | -66.40 | -- | -- | -- | -278.81 | -- | 2.28 | -- | 0.0125 | -- | 107.51 | -- | -50.11 | -- | -- | -- |
| AbL Diagnostics SA | 11.19m | 1.20m | 49.31m | 19.00 | 5.10 | 7.35 | 162.52 | 4.41 | 0.5997 | 0.5997 | 5.58 | 0.4165 | 1.18 | -- | 5.21 | 588,990.50 | 12.67 | 8.99 | 26.09 | 10.77 | 35.76 | 38.29 | 10.75 | 31.17 | 1.28 | -- | 0.31 | 0.00 | -- | 67.89 | 328.77 | -- | -- | -- |
Data as of Apr 30 2024. Currency figures normalised to Shedir Pharma Srl Unipersonale's reporting currency: Euro EUR
1.80%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| Arca Fondi SGR SpAas of 28 Mar 2024 | 186.57k | 1.63% |
| Nextam Partners SGR SpAas of 29 Sep 2023 | 18.75k | 0.16% |
Data from 29 Sep 2023 - 28 Mar 2024Source: FactSet Research Systems Inc.
